[Chronic myeloid leukemia and targeted therapies: too many choices?]

Med Sci (Paris). 2010 Nov;26(11):911-4. doi: 10.1051/medsci/20102611911.
[Article in French]
No abstract available

Publication types

  • News

MeSH terms

  • Antineoplastic Agents / therapeutic use
  • Benzamides
  • Dasatinib
  • Drug Tolerance
  • Humans
  • Imatinib Mesylate
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / therapy*
  • Piperazines / therapeutic use
  • Protein-Tyrosine Kinases / antagonists & inhibitors
  • Pyrimidines / therapeutic use
  • Thiazoles / therapeutic use
  • Time Factors
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Benzamides
  • Piperazines
  • Pyrimidines
  • Thiazoles
  • Imatinib Mesylate
  • Protein-Tyrosine Kinases
  • nilotinib
  • Dasatinib